Zogenix, Inc. Announces Conference Call and Webcast to Present Fourth Quarter and Full Year 2012 Financial Results

SAN DIEGO, March 7, 2013 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced it will release financial results for the fourth quarter and full year ended December 31, 2012, before the market opens on Friday, March 15, 2013, and will hold a conference call on this day at 8:30 a.m. ET (5:30 a.m. PT), to discuss these financial results and provide a company update.

MORE ON THIS TOPIC